Akoya Biosciences (AKYA) IPO Opens 30% Higher

April 16, 2021 12:10 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Today's IPO for Akoya Biosciences, Inc. (NASDAQ: AKYA) opened for trading at $26 after pricing 6,580,000 shares of its common stock at a price of $20.00 per share.

J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Piper Sandler &Co., and Canaccord Genuity LLC are acting as Joint Book-Running Managers for the offering.

As The Spatial Biology Company, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

JPMorgan, Morgan Stanley, Canaccord Genuity, IPO